European Commission approves Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss Read more
Conference Co-Chairs Invite Medical Devices Experts to the Medical Devices & IVD Conference Read more
Evusheld long-acting antibody combination recommended for approval in the EU for the treatment of COVID-19 Read more
bluebird bio Receives FDA Accelerated Approval for SKYSONA Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy (CALD) Read more
Bristol Myers Squibb Receives European Commission Approval for LAG-3-Blocking Antibody Combination, Opdualag (nivolumab and relatlimab), for the Treatment of Unresectable or Metastatic Melanoma with Tumor Cell PD-L1 Expression < 1% Read more
NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A’s Cardio-Metabolic Therapies Read more
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics Read more
WHO Expands Recommendation for Veklury (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline Read more
Meet Pfizer, AstraZeneca, DiME & many more at the Biosensors for Medical Wearables Conference Read more
Avicanna Expands its Epilepsy Research Program with a New Collaboration with the University of Toronto Read more